S.M. Tolaney

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  

S.M. Tolaney
Jan 28, 2025, 15:01 | Insight
Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center
Dana-Farber’s Breast Oncology Center shared a post on X: "Check out the Breast Cancer Research Digest…
Jan 19, 2025, 14:07 | Insight
Aleix Prat: Utility of the HER2DX genomic assay in predicting pCR in HER2+ stage III IBC
Aleix Prat, Director of the Cancer Institute at the Hospital Clinic of Barcelona, shared a…
Dec 21, 2024, 12:45 | Insight
Practical treatment strategies and novel therapies for HR positive/HER2 negative advanced breast cancer
Neil Vasan, Breast oncologist at Herbert Irving Comprehensive Cancer Center, shared a post on X:…
Nov 13, 2024, 11:56 | Blog
HER2-Low Status and Its Impact on Outcomes in Early-Stage Triple-Negative Breast Cancer
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared a post on X:…
Sep 19, 2024, 15:18 | Insight
Paolo Tarantino: Monitoring ADC-related interstitial lung disease
Paolo Tarantino shared a post on LinkedIn: "More sensitive ways are needed to monitor for ADC-related…
Sep 7, 2024, 11:16 | Drugs
Paolo Tarantino: Recommended read on adjuvant ribociclib in preparation for the ESMO24
Oncology Brothers shared a post by Paolo Tarantino on X, adding: “Adjuvant abemaciclib preferred for…
Sep 7, 2024, 10:06 | Blog
Is adjuvant ribociclib ready for prime time?
Sarah Sammons shared a post by Paolo Tarantino, on X: "The number needed to treat (NNT) to…
Sep 6, 2024, 11:25 | Insight
Paolo Tarantino: Interesting RWA of outcomes with chemotherapy in HR+/HER2- MBC
Paolo Tarantino shared a post by ESMO Open on X, adding: "Interesting real world analysis…
All: 8 Posts: 1 - 100
Special Coverage